Surgical Correction of Moderate Ischemic Mitral Regurgitation
May 31, 2011 updated by: Shaare Zedek Medical Center
The purpose of this study is to try and determine whether repair of moderate ischemic mitral regurgitation at the time of coronary bypass graft surgery (CABG) has an impact on survival.We will compare patients undergoing CABG + mitral repair or CABG only groups.
Primary endpoints include late survival.
Secondary endpoints include event free survival, symptoms, and echocardiographic outcomes.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Jerusalem, Israel, 91031
- Shaare Zedek Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients undergoing coronary bypass surgery who have moderate degree of ischemic MR
Description
Inclusion Criteria:
- patients undergoing coronary bypass surgery who have moderate degree of ischemic MR
Exclusion Criteria:
- etiology of mitral regurgitation other than ischemic, degree of regurgitation other than moderate.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
survival at 1,5 and 10 years
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
event free survival
|
|
symptoms
|
|
echocardiographic parameters
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
October 31, 2006
First Submitted That Met QC Criteria
October 31, 2006
First Posted (ESTIMATE)
November 1, 2006
Study Record Updates
Last Update Posted (ESTIMATE)
June 1, 2011
Last Update Submitted That Met QC Criteria
May 31, 2011
Last Verified
May 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IMR001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.